We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

AI Holography System Accurately Checks Quality of Red Blood Cells

By LabMedica International staff writers
Posted on 15 Aug 2022
Print article
Image: AI holography system checks blood quality without injections (Photo courtesy of Pexels)
Image: AI holography system checks blood quality without injections (Photo courtesy of Pexels)

Red blood cells are a major component of blood that carries oxygen. Red blood cells collected through blood donation are stored for a certain period of time until they are used for transfusion when needed. This process is necessary because unhealthy red blood cells do not function properly and may lead to fatal side effects such as acute lung damage. Conventionally, image-based red blood cell analysis technology is used, which is an invasive method that destroys the three-dimensional structure of red blood cells as red blood cells are observed after staining. In addition, there are technical limitations in rapidly analyzing state changes such as three-dimensional shape, density change, and motility characteristics of red blood cells. To overcome this problem, a research team has developed an AI holography system that automatically extracts important information and inspects the quality of red blood cells. The new system is expected to become a key technology for enabling cleaner and healthier red blood cell injections to patients through accurate quality inspection of red blood cells stored for a certain period of time for blood transfusion.

Scientists at Daegu Gyeongbuk Institute of Science and Technology (DGIST, Daegu, Korea) had earlier developed 'holography-based red blood cell division and classification technology.' However, this requires a number of pre-processing algorithms before analysis, which takes a long time, and involves difficulties in performing accurate analysis and classification. In response, the team successfully developed an AI holography system that automatically inspects the quality of red blood cells stored for a certain time by combining the 3D structure image data of red blood cells obtained with holography technology and generative adversarial neural network technology.

If the developed technology is used, it will be possible to automatically extract important values ​​of judgment for red blood cells by applying the automatic red blood cell 3D structural image analysis algorithm and also check its quality. In particular, it is possible to test the quality of red blood cells precisely and simply as there is no need for invasive methods or pre-treatment procedures required by existing technologies. It is expected to be used as a core technology to help minimize the side effects of transfusion by injecting clean and healthy red blood cells to patients needing blood transfusions.

“The technology developed through this research is the source technology that can automatically analyze how red blood cells, stored for transfusion, change their three-dimensional shape depending on the storage period and determine whether stored red blood cells are healthy red blood cells that can be transfused,” said Professor Moon In-kyu of the Department of Robotics and Mechatronics Engineering at DGIST who led the research team. “It is expected that it will help minimize the occurrence of side effects after transfusion in the future as it can check the state of stored red blood cells more minutely and test whether the red blood cells are safe for the patient before transfusion.”

Related Links:
DGIST 

Gold Supplier
Auto Urinary Sediment Analyzer
EH-2030
New
HBV Test
ELISA HBV Test Kit
New
Capillary Electrophoresis System
CAPILLARYS 3 DBS
New
RT-PCR Enzymes and Kits
QuantiNova Pathogen +IC Kit

Print article
IIR Middle East

Channels

Molecular Diagnostics

view channel
Image: Special blood test could determine if patient has early stage breast cancer and if the cancer is unlikely to return (Photo courtesy of USC)

Simple Blood Draw Could Revolutionize Early Breast Cancer Detection

Breast cancer is the most prevalent form of cancer in the world, affecting one in eight women over their lifetime. Since 1976 when the American Cancer Society endorsed mammography X-rays, the technique... Read more

Industry

view channel
Image: The global infectious disease IVD market is expected to hit USD 57 billion by 2030 (Photo courtesy of Pexels)

Global Infectious Disease IVD Market Dominated by Molecular Diagnostics Technology

The global infectious disease in vitro diagnostics (IVD) market stood at USD 113.7 billion in 2021 and is expected to grow at a CAGR of -7.41% from 2022 to 2030 to hit around USD 56.89 billion by 2030,... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.